glp 1 and breast cancer survivor ‘Too Good to Be True?’ GLP-1s Survival GLP-1 medications may improve survival

doi: 10.1016/j.resmic.2010.09.017, 81 Olsson-FrancisK.de la TorreR.CockellC

How to Reduce Risk and Use BPC-157 Responsibly While BPC-157 shows strong promise as a regenerative peptide, its safety depends largely on how you use it

Biosynthesis of Riboflavin and Its Derivatives Riboflavin biosynthesis begins from two major substrates, GTP and Ribu5P, derived from purine biosynthesis or/and the pentose phosphate pathway, containing seven enzymatic steps generating the final product ( C

GLP-1 Injections: The Established Gold Standard For most patients in the UK, GLP-1 injections are the most recognisable form of this treatment

Preclinical studies demonstrate their capacity to reduce retinal ganglion cell apoptosis in diabetic models (Figure 1, this review comprehensively analyzes the mechanistic basis of GLP-1RAs in ocular diseases, synthesizes emerging clinical and preclinical evidence, and underscores their potential to redefine therapeutic strategies for vision-threatening disorders through multi-targeted disease modification

Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs